Home » Clovis Signs Agreement With Ventana to Develop Companion Diagnostic Test
Clovis Signs Agreement With Ventana to Develop Companion Diagnostic Test
Clovis Oncology, Inc. and Ventana Medical Systems, Inc. announced Thursday that they have entered into a collaboration agreement for the development of a human equilibrative nucleoside transporter 1 (hENT1) immunohistochemistry assay, which will be used in Clovis’ CO-101 clinical trials to identify patients with low level tumor expression of hENT1 protein.
StreetInsider
StreetInsider
Upcoming Events
-
07May
-
14May
-
30May